International Consensus Statement on the Clinical and Therapeutic Management of Leber Hereditary Optic Neuropathy

Overview of attention for article published in Journal of Neuro-Ophthalmology, December 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#9 of 1,858)
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 9 news stories from 7 outlets.

Liestal, Switzerland, October 23, 2017 - Santhera Pharmaceuticals (SIX:SANN) announces that the first International Consensus…

Liestal, Switzerland, October 23, 2017 - Santhera Pharmaceuticals (SIX:SANN) announces that the first International Consensus…

Santhera Pharmaceuticals Holding AG /. Verarbeitet und übermittelt durch Nasdaq Corporate Solutions.

Santhera Pharmaceuticals Holding AG / First International Consensus Statement on the Clinical and Therapeutic Management of…

Santhera Pharmaceuticals Holding AG /. Verarbeitet und übermittelt durch Nasdaq Corporate Solutions.

Santhera Pharmaceuticals Holding AG /. Processed and transmitted by Nasdaq Corporate Solutions.

Santhera Pharmaceuticals Holding AG /. Processed and transmitted by Nasdaq Corporate Solutions.